BNF Guidelines for Promethazine Use
Understanding Promethazine Classification
According to BNF guidance, promethazine belongs to the phenothiazine group of sedating antihistamines. This classification indicates its dual action mechanism - blocking histamine receptors peripherally whilst crossing into the central nervous system to produce sedation. The BNF categorises promethazine under both antihistamines and hypnotics, reflecting its versatile therapeutic applications.
BNF Dosage Recommendations
The BNF provides specific dosing schedules for different conditions. For allergic conditions, adults typically require 25mg at night or 10-20mg twice daily. Sleep disturbances may warrant 25-50mg at bedtime, though BNF guidance emphasises short-term use only. EverydayMeds stocks both Phenergan 25mg tablets and 5mg/5ml elixir formulations to accommodate different dosing requirements and patient preferences.
Contraindications and Cautions
BNF guidance highlights important contraindications including severe respiratory depression, comatose states, and children under 2 years. Cautions include elderly patients, those with prostatic enlargement, narrow-angle glaucoma, or severe coronary artery disease. The sedating nature means patients should avoid driving or operating machinery, particularly as effects may persist into the following day.
Drug Interactions from BNF
The BNF documents significant interactions with central nervous system depressants, including alcohol, benzodiazepines, and opioids, which may enhance sedative effects. Anticholinergic effects can be potentiated when combined with tricyclic antidepressants or other antimuscarinic drugs. Healthcare professionals should review concurrent medications before prescribing promethazine.
Available Formulations
EverydayMeds offers both tablet and liquid formulations referenced in BNF guidance. The 25mg tablet strength provides convenient dosing for adults, whilst the 5mg/5ml elixir offers flexible dosing options and easier administration for those who struggle with tablets. Both formulations deliver equivalent therapeutic effects when dosed appropriately according to BNF recommendations.
